Background: Genetic variants of the two adjacent genes, IL13 and IL4 have frequently been reported as being associated with susceptibility to atopy and asthma, both in adults and children, and some studies also suggest association with lung function and chronic obstructive pulmonary disease.

Methods: In this study, we examined for the first time the effect of these variants in 2918 adults in a longitudinal birth cohort, the British National Survey of Health and Development, where there are extensive life style, developmental and environmental data. We examine two IL13 single nucleotide polymorphisms (SNPs) IL13 rs20541 (R110Q) and rs1800925 (-1024C>T) and one IL4 SNP, rs2070874 (-33C>T) with likely function.

Results: We show that IL13 rs20541 and rs1800925 are each significantly associated with self-reported asthma and allergy, and that this association is not confounded by any of the known developmental and environmental risk factors for asthma and atopy, including in particular place of birth. IL13 rs20541 does however act as a confounder for the IL13 rs1800925 associations, meaning that there is no statistical support for rs1800925 having an independent effect. There is nevertheless evidence for interaction between smoking and rs1800925, with allergy as outcome. None of the SNPs showed association with measures of lung function, nor any interaction with the effect of smoking on lung function.

Conclusion: In a longitudinal population cohort we have established a role for polymorphism of IL13 in determining susceptibility to both atopy and asthma.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1398-9995.2009.01988.xDOI Listing

Publication Analysis

Top Keywords

il13 rs20541
12
il13
8
birth cohort
8
susceptibility atopy
8
atopy asthma
8
lung function
8
developmental environmental
8
interaction smoking
8
asthma
5
rs1800925
5

Similar Publications

gene polymorphisms among Sudanese patients with bronchial asthma: a case-control study.

Mol Biol Res Commun

January 2025

Department of Pathology, College of Medicine, Qassim University, Saudi Arabia.

Article Synopsis
  • Genetic variations in the interleukin-13 gene may influence asthma risk across different ethnic groups, and this study focused on two specific genetic polymorphisms in Sudanese patients.
  • A case-control study involved 50 asthmatic patients and 50 control individuals, using a specialized genetic testing method to analyze the polymorphisms.
  • Results indicated that the rs1800925 polymorphism is significantly linked to increased asthma susceptibility, while the rs20541 polymorphism showed no association with the condition.
View Article and Find Full Text PDF

Impact of IL13 genetic polymorphisms on COPD susceptibility in the Chinese Han population.

Respir Med

December 2024

Department of Pulmonary and Critical Care Medicine, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570311, Hainan, China. Electronic address:

Background: Chronic obstructive pulmonary disease (COPD) is characterized by persistent respiratory symptoms and airflow limitation. Interleukin-13 (IL13), associated with T-helper type 2 cells, plays a crucial role in COPD pathophysiology. This study aimed to investigate the relationship of single nucleotide polymorphisms (SNPs) in IL13 to COPD risk.

View Article and Find Full Text PDF

Background: Inflammatory cytokines play a major role in the pathogenesis of myocardial infarction (MI). Although information on the importance of interleukin 13 (IL13) in human MI is limited, it has been well documented in the mouse model. Genetic variation in the IL13 gene has been associated with the structure and expression of the IL13.

View Article and Find Full Text PDF

The interleukin 13 (IL-13) gene single nucleotide polymorphisms (SNPs) are frequently linked to increased vulnerability to allergic asthma. Forkhead box protein P3 (FOXP3) is an important molecule in the formation of regulatory T cells (Treg). The genetic variants that alter FOXP3 function may have a role in the development of asthma and other allergic disorders.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the potential link between IL-13 inhibition (using medication like dupilumab) and the risk of developing psoriatic arthritis (PsA) and psoriasis, amidst reports of adverse effects resembling psoriatic disease following treatment.* -
  • Using genetic data from a large cohort, researchers found that genetically mimicked IL-13 inhibition is significantly associated with an increased risk of PsA (odds ratio 37.39) and psoriasis (odds ratio 20.08), with no strong evidence of confounding factors from other diseases.* -
  • The results suggest that healthcare providers should be cautious when prescribing IL-13 inhibitors, as there is genetic evidence indicating a potential risk for these skin conditions.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!